Literature DB >> 28209591

Psychosocial therapies for the adjunctive treatment of bipolar disorder in adults: network meta-analysis.

Mary Lou Chatterton1, Emily Stockings2, Michael Berk2, Jan J Barendregt2, Rob Carter2, Cathrine Mihalopoulos2.   

Abstract

BackgroundFew trials have compared psychosocial therapies for people with bipolar affective disorder, and conventional meta-analyses provided limited comparisons between therapies.AimsTo combine evidence for the efficacy of psychosocial interventions used as adjunctive treatment of bipolar disorder in adults, using network meta-analysis (NMA).MethodSystematic review identified studies and NMA was used to pool data on relapse to mania or depression, medication adherence, and symptom scales for mania, depression and Global Assessment of Functioning (GAF).ResultsCarer-focused interventions significantly reduced the risk of depressive or manic relapse. Psychoeducation alone and in combination with cognitive-behavioural therapy (CBT) significantly reduced medication non-adherence. Psychoeducation plus CBT significantly reduced manic symptoms and increased GAF. No intervention was associated with a significant reduction in depression symptom scale scores.ConclusionsOnly interventions for family members affected relapse rates. Psychoeducation plus CBT reduced medication non-adherence, improved mania symptoms and GAF. Novel methods for addressing depressive symptoms are required. © The Royal College of Psychiatrists 2017.

Entities:  

Mesh:

Year:  2017        PMID: 28209591     DOI: 10.1192/bjp.bp.116.195321

Source DB:  PubMed          Journal:  Br J Psychiatry        ISSN: 0007-1250            Impact factor:   9.319


  8 in total

1.  Ethical Issues in the Diagnosis and Treatment of Bipolar Disorders.

Authors:  Michael J Ostacher
Journal:  Focus (Am Psychiatr Publ)       Date:  2019-07-16

2.  20-Year Trends in the Pharmacologic Treatment of Bipolar Disorder by Psychiatrists in Outpatient Care Settings.

Authors:  Taeho Greg Rhee; Mark Olfson; Andrew A Nierenberg; Samuel T Wilkinson
Journal:  Am J Psychiatry       Date:  2020-04-21       Impact factor: 18.112

3.  Transdiagnostic treatment of bipolar disorder and comorbid anxiety using the Unified Protocol for Emotional Disorders: A pilot feasibility and acceptability trial.

Authors:  Kristen K Ellard; Emily E Bernstein; Casey Hearing; Ji Hyun Baek; Louisa G Sylvia; Andrew A Nierenberg; David H Barlow; Thilo Deckersbach
Journal:  J Affect Disord       Date:  2017-05-10       Impact factor: 4.839

4.  COVID-19 lockdown - who cares? The first lockdown from the perspective of relatives of people with severe mental illness.

Authors:  Erlend Mork; Sofie R Aminoff; Elizabeth Ann Barrett; Carmen Simonsen; Wenche Ten Velden Hegelstad; Trine Vik Lagerberg; Ingrid Melle; Kristin Lie Romm
Journal:  BMC Public Health       Date:  2022-06-02       Impact factor: 4.135

5.  Targets and outcomes of psychotherapies for mental disorders: an overview.

Authors:  Pim Cuijpers
Journal:  World Psychiatry       Date:  2019-10       Impact factor: 49.548

6.  Efficacy of the interpersonal and social rhythm therapy (IPSRT) in patients with bipolar disorder: results from a real-world, controlled trial.

Authors:  Luca Steardo; Mario Luciano; Gaia Sampogna; Francesca Zinno; Pasquale Saviano; Filippo Staltari; Cristina Segura Garcia; Pasquale De Fazio; Andrea Fiorillo
Journal:  Ann Gen Psychiatry       Date:  2020-03-09       Impact factor: 3.455

7.  The Long-Term Effectiveness of Psychoeducation for Bipolar Disorders in Mental Health Services. A 4-Year Follow-Up Study.

Authors:  Chiara Buizza; Valentina Candini; Clarissa Ferrari; Alberto Ghilardi; Francesco Maria Saviotti; Cesare Turrina; Gianluigi Nobili; Margherita Sabaudo; Giovanni de Girolamo
Journal:  Front Psychiatry       Date:  2019-11-26       Impact factor: 4.157

8.  Psychoeducation in bipolar disorder: A systematic review.

Authors:  Juliana Lemos Rabelo; Breno Fiuza Cruz; Jéssica Diniz Rodrigues Ferreira; Bernardo de Mattos Viana; Izabela Guimarães Barbosa
Journal:  World J Psychiatry       Date:  2021-12-19
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.